Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters
European Journal of Pediatrics · 04.09.2024 · 183 (11) · 4789-4797
DOI: 10.1007/s00431-024-05746-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pediatrics, online erschienen am 04.09.2024. Verfasst von Alexandru-Ștefan Niculae und 3 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Pediatrics, Iuliu Hațieganu University of Medicine and Pharmacy, 3-5 Crișan Street, Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Cardiomyopathies, Liver Cirrhosis, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Liver cirrhosis is a significant global health concern, and cirrhotic cardiomyopathy (CCM) is a notable complication affecting both adults and children. While CCM is well-studied in adults, understanding its manifestation and diagnostic criteria in pediatric patients remains a challenge. This review explores the evidence for structural and functional cardiac alterations in children with liver cirrhosis. Structural abnormalities, including increased left ventricular mass index (LVMI) and altered left ventricular wall thickness ratios, are prevalent in pediatric CCM. These abnormalities persist even after liver transplantation, highlighting the systemic impact of liver disease. Evidence suggests that altered systolic and diastolic function, as well as electrocardiographic abnormalities such as prolonged QT intervals, are common in pediatric CCM. Blood biomarkers, including brain natriuretic peptide (BNP) and troponin levels, offer insights into cardiac function in pediatric cirrhotic patients. Elevated BNP levels correlate with adverse outcomes, indicating its potential as a prognostic marker. However, further research is needed to elucidate the diagnostic utility of these biomarkers in pediatric CCM. Conclusion : This review provides estimates of the standardized mean difference among selected cardiac parameters in children with and without cirrhosis. Tailored diagnostic criteria and comprehensive assessment methods will be essential for accurate diagnosis and effective management of pediatric CCM. What is Known: • CCM adds to the burden of care of patients with cirrhosis. • Diagnostic criteria for adults are evolving, but there are no specific criteria for pediatric CCM. What is New: • Cardiac function in children with cirrhosis indicates some parameters not considered in adults are altered. • Effect size estimations for certain parameters provide a guideline for future research into pediatric CCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Pediatrics, Iuliu Hațieganu University of Medicine and Pharmacy, 3-5 Crișan Street, Cluj-Napoca, Romania.
- 2nd Department of Pediatrics, Iuliu Hațieganu University of Medicine and Pharmacy, 3-5 Crișan Street, Cluj-Napoca, Romania. gramaalina16@elearn.umfcluj.ro.
Zitieren
APA
Niculae, A. Ș., Căinap, S. S., Grama, A., & Pop, T. L. (2024). Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters. European Journal of Pediatrics, 183(11), 4789-4797. https://doi.org/10.1007/s00431-024-05746-6
Vancouver
Niculae AȘ, Căinap SS, Grama A, Pop TL. Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters. European Journal of Pediatrics. 2024;183(11):4789-4797. doi:10.1007/s00431-024-05746-6
BibTeX
@article{Niculae2024,
author = {Niculae, Alexandru-Ștefan and Căinap, Simona Sorana and Grama, Alina and Pop, Tudor Lucian},
title = {Pediatric cirrhotic cardiomyopathy: literature review and effect size estimations of selected parameters},
journal = {European Journal of Pediatrics},
year = {2024},
volume = {183},
number = {11},
pages = {4789--4797},
doi = {10.1007/s00431-024-05746-6}
}
EUVIMED